scispace - formally typeset
N

Naoki Ito

Researcher at Foundation for Biomedical Research

Publications -  32
Citations -  1788

Naoki Ito is an academic researcher from Foundation for Biomedical Research. The author has contributed to research in topics: Skeletal muscle & Muscle hypertrophy. The author has an hindex of 17, co-authored 32 publications receiving 1419 citations. Previous affiliations of Naoki Ito include Fujifilm Holdings Corporation & Tokyo Institute of Technology.

Papers
More filters
Journal ArticleDOI

Crosstalk between Glucocorticoid Receptor and Nutritional Sensor mTOR in Skeletal Muscle

TL;DR: It is shown that direct target genes of the glucocorticoid receptor (GR) in skeletal muscle, i.e., REDD1 and KLF15 inhibits mTOR activity, but via a distinct mechanism involving BCAT2 gene activation, and GR is a liaison involving a variety of downstream molecular cascades toward muscle atrophy.
Journal ArticleDOI

Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy

TL;DR: Findings identify nitric oxide, peroxynitrite and [Ca2+]i as the crucial mediators that convert a mechanical load into an intracellular signaling pathway and lead to suggest that TRPV1 could be a new therapeutic target for treating muscle atrophy.
Journal ArticleDOI

Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy.

TL;DR: This study quantified the expression levels of miRNAs in serum of the dystrophin-deficient muscular dystrophy mouse model, mdx, and the canine X-linked muscular Dystrophy in Japan dog model, CXMDJ, by real-time PCR and found that the serum levels of several muscle-specific mi RNAs are increased in both mdx and CX MDJ.
Journal ArticleDOI

A muscle-liver-fat signalling axis is essential for central control of adaptive adipose remodelling

TL;DR: This work demonstrates that the resulting depletion of plasma alanine serves as a cue to increase plasma levels of fibroblast growth factor 21 and activates liver-fat communication, leading to the activation of lipolytic genes in adipose tissues.